About us Contacts Drug interactions: 390 212
Drug search by name

Fluvoxamine Tablets and Theo-Dur

Determining the interaction of Fluvoxamine Tablets and Theo-Dur and the possibility of their joint administration.

Check result:
Fluvoxamine Tablets <> Theo-Dur
Relevance: 05.10.2023 Reviewer: Shkutko P.M., M.D., in

In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.

Consumer:

FluvoxaMINE may significantly increase the blood levels of theophylline, which may lead to potentially serious and life-threatening side effects. Talk to your doctor if you have any questions or concerns. Your doctor may be able to prescribe alternatives that do not interact, or you may need a dose adjustment or more frequent monitoring by your doctor to safely use both medications. Contact your doctor if you develop nausea, vomiting, diarrhea, loss of appetite, headache, tremor, confusion, restlessness, insomnia, seizures, heart palpitations, and/or irregular heartbeat, as these may be signs and symptoms of excessive theophylline levels. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Professional:

GENERALLY AVOID: Coadministration with fluvoxamine may significantly increase the serum concentrations of theophylline and the associated risk of toxicity. The mechanism is fluvoxamine inhibition of theophylline metabolism via CYP450 1A2. Case reports and pharmacokinetic studies indicate that fluvoxamine 50 to 100 mg/day can reduce the clearance of theophylline by 50% to 70%, resulting in toxic theophylline levels and/or clinical toxicity in some patients. Two- to fourfold increases in theophylline serum levels or systemic exposure (AUC) and half-life have been reported, with onset of clinical toxicity as early as two to three days and typically within a week of initiating fluvoxamine. Patients with liver dysfunction may be less susceptible to the interaction. In a study consisting of 10 healthy subjects, 10 subjects with mild hepatic impairment (Child class A) and 10 subjects with severe hepatic impairment (Child class C), fluvoxamine-induced inhibition of theophylline clearance was reduced from 62% in healthy subjects to 52% and 12% in subjects with mild and severe cirrhosis, respectively. These differences may be due to reduced hepatic uptake of fluvoxamine as well as reduced hepatic expression of CYP450 1A2 in the cirrhotic liver.

MANAGEMENT: The use of theophylline or its salts in combination with fluvoxamine should generally be avoided. If coadministration is required, a reduction of theophylline dosage by one-half to two-thirds should be considered. Pharmacologic response and serum levels should be closely monitored following initiation, discontinuation or change of dosage of fluvoxamine, and the theophylline dosage adjusted accordingly. Patients should be advised to contact their physician if they experience signs and symptoms suggestive of theophylline toxicity such as nausea, vomiting, diarrhea, anorexia, headache, tremor, irritability, confusion, insomnia, seizure, palpitation, and arrhythmia. Other selective serotonin reuptake inhibitors including citalopram, escitalopram, fluoxetine, paroxetine, and sertraline do not significantly inhibit CYP450 1A2 and may be safer alternatives in theophylline-treated patients.

References
  • Orlando R, Padrini R, Perazzi M, De Martin S, Piccoli P, Palatini P "Liver dysfunction markedly decreases the inhibition of cytochrome P450 1A2-mediated theophylline metabolism by fluvoxamine." Clin Pharmacol Ther 79 (2006): 489-99
  • Brosen K, Skjelbo E, Rasmussen BB, Poulsen HE, Loft S "Fluvoxamine is a potent inhibitor of cytochrome P4501A2." Biochem Pharmacol 45 (1993): 1211-4
  • Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
  • Sperber AD "Toxic interaction between fluvoxamine and sustained release theophylline in an 11-year-old boy." Drug Saf 6 (1991): 460-2
  • Devane CL, Markowitz JS, Hardesty SJ, Mundy S, Gill HS "Fluvoxamine-induced theophylline toxicity." Am J Psychiatry 154 (1997): 1317-8
  • Rasmussen BB, Jeppesen U, Gaist D, Brosen K "Griseofulvin and fluvoxamine interactions with the metabolism of theophylline." Ther Drug Monit 19 (1997): 56-62
  • van den Brekel AM, Harriington L "Toxic effects of theophylline caused by fluoxamine." CMAJ 151 (1994): 1289-90
  • Nemeroff CB, Devane CL, Pollock BG "Newer antidepressants and the cytochrome p450 system." Am J Psychiatry 153 (1996): 311-20
  • Rasmussen BB, Maenpaa J, Pelkonen O, et al "Selective serotonin reuptake inhibitors and theophylline metabolism in human liver microsomes: potent inhibition by fluvoxamine." Br J Clin Pharmacol 39 (1995): 151-9
  • Yao C, Kunze KL, Kharasch ED, et al. "Fluvoxamine-theophylline interaction: Gap between in vitro and in vivo inhibition constants toward cytochrome P4501A2." Clin Pharmacol Ther 70 (2001): 415-24
  • "Product Information. Luvox (fluvoxamine)." Solvay Pharmaceuticals Inc, Marietta, GA.
  • Hardman JG, Gilman AG, Limbird LE eds. "Goodman and Gilman's the Pharmacological Basis of Therapeutics. 9th ed." New York, NY: McGraw-Hill (1995):
Fluvoxamine Tablets

Generic Name: fluvoxamine

Brand name: Luvox, Luvox CR

Synonyms: Fluvoxamine

Theo-Dur

Generic Name: theophylline

Brand name: Elixophyllin, Theo-24, Respbid, T-Phyl, Aerolate III, Slo-Bid Gyrocaps, Slo-Phyllin, Theobid, Theo-Dur, Theolair, Theovent, Bronkodyl, Theo-X, Theo-Time, Theochron, Slo-Phyllin 125, Theoclear LA-130, Aerolate JR, Theolair-SR, Theoclear LA-260, Quibron-T, Quibron-T/SR, Uniphyl, Uni-Dur, Aerolate SR, Slo-Phyllin 80, Theoclear-80, Theo-Dur Sprinkles, Theosol-80, Asmalix, Aquaphyllin, Truxophyllin, Slo-Phyllin 250, TheoCap

Synonyms: Theo-Dur (Oral)

In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.

Interaction with food and lifestyle
Disease interaction